🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
Antiretroviral therapy or ART blocks HIV replication reducing plasma viral ...
Status
Recruiting
Location
Unity Health Toronto -St. Michael's Hospital
Start Date
2025-01-14
Trial ID
NCT06823596
Treatments Being Tested
The primary objective of this study is to verify the safety of antigen-spec...
Status
Terminated
Location
Shenzhen Geno-immune Medical Institute
Start Date
2026-06-01
Trial ID
NCT04085159
Treatments Being Tested
This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-02-02
Trial ID
NCT04233294
Treatments Being Tested
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Heal...
Status
Enrolling By Invitation
Location
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)
Start Date
2025-10-23
Trial ID
NCT07221565
Urinary T lymphocytes may be predictive for clinical outcome in patients wi...
Status
Unknown
Location
Charité - Universitätsmedizin Berlin
Start Date
2019-11-19
Trial ID
NCT04320667
Treatments Being Tested
Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...
Status
Recruiting
Location
Hospital General Universitario de Alicante
Start Date
2025-02-04
Trial ID
NCT06431633
Treatments Being Tested
Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS) is a common ...
Status
Recruiting
Location
CHU de Saint-Etienne
Start Date
2025-07-02
Trial ID
NCT06706102
Treatments Being Tested
This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07492888
This a prospective, multicenter, observational pharmacological translationa...
Status
Not Yet Recruiting
Location
Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS
Start Date
2026-10
Trial ID
NCT07767799
Treatments Being Tested